References
Canalis E, Pash J, Varghese S (1993) Skeletal growth factors. Crit Rev Eukaryot Gene Express 3:155–166
Delany AM, Pash J, Canalis E (1994) Cellular and clinical perspectives on skeletal insulin-like growth factor I. J Cell Biochem 55:328–333
Hammerman MR (1987) Insulin-like growth factors and aging. Endocinol Metab Clin North Am 16:995–1008
Romagnoli E, Minisola S, Carnevale V, Rosso R, Pacitti MT, Scarda A, Scarnecchia L, Mazzuoli G (1994) Circulating levels of insulin-like growth factor binding protein 3 (IGFBP-3) and insulin-like growth factor I (IGF-I) in perimenopausal women. Osteoporos Int 4:305–308
Romagnoli E, Minisola S, Carnevale V, Scarda A, Rosso R, Scarnecchia L, Pacitti MT, Mazzuoli G (1993) Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53:1–6
Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR (1994) Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78:1011–1016
Delany AM, Dong Y, Canalis E (1994) Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 56:295–302
Canalis E (1992) Clinical review 35: growth factors and their potential clinical value. J Clin Endocrinol Metab 75:1–4
Canalis E (1995) Growth hormone, skeletal growth factors and osteoporosis. Endocr Pract 1:39–43
Clemmons DR (1992) Editorial: role of insulin-like growth factor-I in reversing catabolism. J Clin Endocrinol Metab 75: 1183–1196
Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL (1993) Short-term effects of recombinant human insulin-like growth factor-I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384–1387
Grinspoon SK, Baum HBA, Peterson S, Kilbanski A (1995) Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96:900–906
Canalis E, Centrella M, Burch M, McCarthy TL (1989) Insulin-like growth factor I mediates selected anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60–65
Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM (1994) Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:1618–1623
Author information
Authors and Affiliations
Additional information
Supported by grants DK42424 and DK45227 from the National Institute of Diabetes Digestive and Kidney Diseases
Rights and permissions
About this article
Cite this article
Canalis, E., Agnusdei, D. Insulin-like growth factors and their role in osteoporosis. Calcif Tissue Int 58, 133–134 (1996). https://doi.org/10.1007/BF02526877
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02526877